Rubicon Research is poised for a significant earnings surge, driven by its focus on specialty generics, nasal therapies, and branded formulations, according to Investec’s latest research note.
HCLTech’s Q3 results have led to a hike in target price by brokerages, driven by the company’s standout performance in the October-December period.
Tata Consultancy Services Ltd.’s Q3 performance drew mixed reactions from brokerages, with the Street broadly agreeing that while the quarter was largely in line on headline numbers, underlying trends in international markets remain soft.
Japanese stocks rally to all-time highs on speculation of a snap election, while government bonds slump. What does this mean for Indian investors and the global market landscape?
HCL Technologies Ltd. has announced an interim dividend of Rs 12 for the third quarter of the ongoing financial year. Check the record date, payout details, and eligibility criteria for investors.
Alphabet Inc., the parent company of Google, has surpassed a $4 trillion market capitalization. We analyze what this means for Indian investors and the broader AI landscape.
Get the latest insights on hospital stocks in India, including Jefferies’ top picks and the key factors driving growth in the sector.
Tata Consultancy Services (TCS) has reported its Q3 results, and the numbers are inline with expectations. Yes Securities remains positive on the stock, citing a broad-based recovery in revenue growth and resilient margins.
Tata Consultancy Services (TCS) expects 2025 to be a transformative year for Artificial Intelligence (AI), with the company witnessing a surge in AI-focused annualised revenue to $1.8 billion.
HCLTech’s Q3 results beat expectations, but Dolat Capital downgrades the shares to ‘Reduce’. What’s behind this move and how will it impact Indian investors?